A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report

BACKGROUND: Patients receiving immune checkpoint inhibitors have been reported to develop autoimmune endocrine diseases, including type 1 diabetes, although few drugs have been shown to induce type 1 diabetes. Additionally, it is important to note that drugs other than immune checkpoint inhibitors c...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyabayashi, Makoto, Onishi, Shunichiro, Yoshida, Tomohiko, Takemoto, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881334/
https://www.ncbi.nlm.nih.gov/pubmed/36703182
http://dx.doi.org/10.1186/s13256-023-03755-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881334/
https://www.ncbi.nlm.nih.gov/pubmed/36703182
http://dx.doi.org/10.1186/s13256-023-03755-x

Ejemplares similares